| All LTs (n = 122) | PRS (n = 65) | no PRS (n = 57) | P |
---|---|---|---|---|
Donor characteristics | ||||
Age [years] | 55.2 ± 16.2 | 57.1 ± 15.1 | 53.1 ± 17.2 | 0.18 |
Sex [female] | 57 (46.7%) | 32 (49.2%) | 24 (42.1%) | 0.42 |
BMI [kg/cm2] | 28.8 ± 7.2 | 31.1 ± 8.2 | 26.4 ± 4.8 | < 0.001 |
Sodium [mmol/L] | 147.7 ± 8.2 | 149.1 ± 7.8 | 146.1 ± 8.4 | 0.04 |
ALT [U/L] | 114.2 ± 289.6 | 106.7 ± 223.2 | 122.8 ± 352.4 | 0.77 |
AST [U/L] | 124.4 ± 237.8 | 115.9 ± 182.1 | 134.1 ± 290.0 | 0.69 |
Bilirubine [mg/dL] | 0.86 ± 1.23 | 0.80 ± 1.33 | 0.93 ± 1.13 | 0.59 |
Cold ischemic time [h] | 8.3 ± 2.3 | 8.7 ± 2.3 | 7.8 ± 2.3 | 0.04 |
  ≥ 10 h [n] | 23 (18.9%) | 17 (26.2%) | 6 (10.5%) | 0.02 |
Warm ischemic time [min] | 43.7 ± 7.5 | 44.9 ± 6.7 | 42.3 ± 8.2 | 0.06 |
Recipient characteristics | ||||
Age [years] | 54.9 ± 9.8 | 55.2 ± 9.8 | 54.5 ± 9.8 | 0.69 |
Sex [female] | 43 (35.2%) | 21 (32.3%) | 22 (38.6%) | 0.57 |
BMI [kg/cm2] | 27.6 ± 5.3 | 27.3 ± 5.5 | 28.1 ± 5.0 | 0.41 |
Diagnosis [n] | ||||
 acute liver failure | 12 (9.8%) | 10 (15.4%) | 2 (3.5%) | 0.03 |
 acute on chronic | 5 (4.1%) | 1 (1.5%) | 4 (7.0%) | 0.18 |
 cirrhosis | 57 (46.7%) | 20 (30.8%) | 37 (64.9%) | < 0.001 |
 tumor | 25 (20.5%) | 14 (21.5%) | 11 (19.3%) | 0.82 |
 graft failure | 7 (5.7%) | 2 (3.1%) | 5 (8.8%) | 0.25 |
 others (PSC, polycystic) | 16 (13.1%) | 10 (15.4%) | 6 (10.5%) | 0.59 |
portal hypertension | 85 (69.7%) | 52 (80.0%) | 33 (57.9%) | 0.01 |
labMELD | 19.8 ± 10.3 | 20.0 ± 9.9 | 19.6 ± 10.8 | 0.82 |
Creatinine preop [mg/dl] | 1.71 ± 1.49 | 1.75 ± 0.23 | 1.66 ± 0.15 | 0.14 |
preoperative RRT [n] | 15 (12.3%) | 8 (12.3%) | 7 (12.3%) | 1.00 |